Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature.

Elise FournierLuca InchiappaCarole DelattreJean-Michel PignonFrédérique DanicourtMaxime BembaCatherine Roche-LestienneAgnès DaudignonGauthier DecoolChristophe RoumierFlorent DumezyLoïc FournierNathalie GrardelClaude PreudhommeNicolas Duployez

Published in: Leukemia & lymphoma (2019)

Keyphrases

acute lymphoblastic leukemia
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
cancer therapy
nk cells
drug delivery